{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:57:31Z","timestamp":1773161851572,"version":"3.50.1"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["106680\/Z\/14\/Z"],"award-info":[{"award-number":["106680\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0240830","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T17:26:06Z","timestamp":1603214766000},"page":"e0240830","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5904-5970","authenticated-orcid":true,"given":"Vu Quoc","family":"Dat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phan Khanh","family":"Toan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9807-1821","authenticated-orcid":true,"given":"H. Rogier","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Louise","family":"Thwaites","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behzad","family":"Nadjm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,10,20]]},"reference":[{"issue":"15","key":"pone.0240830.ref001","doi-asserted-by":"crossref","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015","volume":"115","author":"EY Klein","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0240830.ref002","doi-asserted-by":"crossref","DOI":"10.1787\/health_glance-2017-en","volume-title":"Health at a Glance 2017: OECD Indicators:","author":"OECD","year":"2017"},{"issue":"8","key":"pone.0240830.ref003","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data","volume":"14","author":"TP Van Boeckel","year":"2014","journal-title":"The Lancet Infectious diseases"},{"issue":"9459","key":"pone.0240830.ref004","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)70799-6","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study","volume":"365","author":"H Goossens","year":"2005","journal-title":"Lancet"},{"key":"pone.0240830.ref005","unstructured":"World Health Organization. WHO model list of essential medicines, 20th list (\u200eMarch 2017, amended August 2017)\u200e 2017. Available from: http:\/\/www.who.int\/iris\/handle\/10665\/273826."},{"key":"pone.0240830.ref006","unstructured":"World Health Organization. The 2019 AWaRe Classification Antibiotics 2019 [cited 2019 10th October]. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/327957\/WHO-EMP-IAU-2019.11-eng.xlsx?ua=1."},{"key":"pone.0240830.ref007","unstructured":"World Health Assembly. Global action plan on antimicrobial resistance. Geneva: World Health Organization; 2015. 3 p. p."},{"key":"pone.0240830.ref008","unstructured":"World Health Organization. Global Health Expenditure Database. Health Expenditure Profile of Viet Nam 2018 [cited 2019 22nd March 2019]. Available from: http:\/\/apps.who.int\/nha\/database\/country_profile\/Index\/en."},{"key":"pone.0240830.ref009","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jgar.2019.06.002","article-title":"Antimicrobial susceptibility testing and antibiotic consumption results from 16 hospitals in Viet Nam: The VINARES project 2012\u20132013","volume":"18","author":"TVD Vu","year":"2019","journal-title":"Journal of global antimicrobial resistance"},{"key":"pone.0240830.ref010","year":"2018"},{"key":"pone.0240830.ref011","unstructured":"Ministry of Health. Bidding for supply of drugs for public health facilities, issued with Decision No. 11\/2016\/TT-BYT. 2016."},{"key":"pone.0240830.ref012","unstructured":"Common index codes applied in medical examination and treatment and payment of health insurance, 3465\/Q\u0110-BYT (2016)."},{"key":"pone.0240830.ref013","unstructured":"General Statistics Office. Statistical summary book of Vietnam 2017: Statistical publishing house; 2018. Available from: http:\/\/www.gso.gov.vn\/default.aspx?tabid=384&idmid=&ItemID=18938."},{"key":"pone.0240830.ref014","unstructured":"Ministry of Health. Report on healthcare system in 2019 and the priorities and goals for 2020. 2019;1611\/BC-BYT."},{"key":"pone.0240830.ref015","unstructured":"The detailed regulation on technical decentralization in care and treatment systems, 43\/2013\/TT-BYT (2013)."},{"key":"pone.0240830.ref016","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcrc.2017.07.020","article-title":"Healthcare infrastructure capacity to respond to severe acute respiratory infection (SARI) and sepsis in Vietnam: A low-middle income country","volume":"42","author":"VQ Dat","year":"2017","journal-title":"Journal of critical care"},{"key":"pone.0240830.ref017","unstructured":"Drug Administration of Vietnam. Summary of bid-winning results of national and provincial hospitals in public hospitals under the Ministry of Health by 24\/11\/2017 2018 [cited 2018 13th January 2018]. Available from: http:\/\/www.dav.gov.vn\/?action=detail&newsid=1758&type=3."},{"key":"pone.0240830.ref018","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC classification index with DDDs 2018. Oslo, Norway2018."},{"key":"pone.0240830.ref019","unstructured":"WHO International Working Group for DrugStatistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical PharmacologicalServices. Introduction to drug utilization research. Oslo, Norway: World Health Organization,; 2003."},{"key":"pone.0240830.ref020","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2018. Oslo, Norway2017."},{"key":"pone.0240830.ref021","unstructured":"The World Bank Group. World Development Indicators: Exchange rates and prices 2019 [cited 2019 21st March]. Available from: http:\/\/wdi.worldbank.org\/table\/4.16."},{"key":"pone.0240830.ref022","volume-title":"MDS-3: managing access to medicines and health technologies","author":"MA Embrey","year":"2013","edition":"3"},{"key":"pone.0240830.ref023","author":"World Health O","year":"2018"},{"key":"pone.0240830.ref024","volume-title":"International Medical Products Price Guide","author":"Management Sciences for Health (MSH)","year":"2015"},{"key":"pone.0240830.ref025","unstructured":"Business Monitor International Ltd. Vietnam Pharmaceuticals & Healthcare Report Q4 2016. London, United Kingdom: 2016."},{"issue":"7","key":"pone.0240830.ref026","doi-asserted-by":"crossref","first-page":"e861","DOI":"10.1016\/S2214-109X(19)30071-3","article-title":"Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries","volume":"7","author":"Y Hsia","year":"2019","journal-title":"The Lancet Global health"},{"issue":"1","key":"pone.0240830.ref027","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(17)30724-7","article-title":"Classifying antibiotics in the WHO Essential Medicines List for optimal use-be AWaRe","volume":"18","author":"M Sharland","year":"2018","journal-title":"The Lancet Infectious diseases"},{"key":"pone.0240830.ref028","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial consumption: Annual epidemiological reportfor 2017. Stockholm: 2018."},{"issue":"6","key":"pone.0240830.ref029","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","article-title":"Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey","volume":"6","author":"A Versporten","year":"2018","journal-title":"The Lancet Global health"},{"issue":"1","key":"pone.0240830.ref030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12879-017-2582-7","article-title":"Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome","volume":"17","author":"VQ Dat","year":"2017","journal-title":"BMC infectious diseases"},{"key":"pone.0240830.ref031","article-title":"Antibiotic consumption in Shandong Province, China: an analysis of provincial pharmaceutical centralized bidding procurement data at public healthcare institutions, 2012\u201316","author":"J Yin","year":"2017","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"3","key":"pone.0240830.ref032","doi-asserted-by":"crossref","first-page":"e0117710","DOI":"10.1371\/journal.pone.0117710","article-title":"Systematic review on irrational use of medicines in China and Vietnam","volume":"10","author":"W Mao","year":"2015","journal-title":"PloS one"},{"issue":"11","key":"pone.0240830.ref033","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/cid\/cix634","article-title":"Trends in Pricing and Generic Competition Within the Oral Antibiotic Drug Market in the United States. Clinical infectious diseases: an official publication of the","volume":"65","author":"JD Alpern","year":"2017","journal-title":"Infectious Diseases Society of America"},{"key":"pone.0240830.ref034","unstructured":"National Institute for Health and Care Excellence (NICE). Cephalosporins 2020 [cited 2020 20 th January]. Available from: https:\/\/bnf.nice.org.uk\/treatment-summary\/cephalosporins.html."},{"key":"pone.0240830.ref035","first-page":"2","article-title":"Medicine prices, availability, and affordability in Vietnam","author":"AT Nguyen","year":"2009","journal-title":"Southern Med Review"},{"issue":"5","key":"pone.0240830.ref036","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/heapol\/czw174","article-title":"Inflated medicine prices in Vietnam: a qualitative study","volume":"32","author":"TA Nguyen","year":"2017","journal-title":"Health Policy Plan"},{"key":"pone.0240830.ref037","author":"World Health Organization","year":"2008"},{"issue":"9","key":"pone.0240830.ref038","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph14090976","article-title":"Pharmaceutical Industry in Vietnam: Sluggish Sector in a Growing Market","volume":"14","author":"A Angelino","year":"2017","journal-title":"International journal of environmental research and public health"},{"issue":"1","key":"pone.0240830.ref039","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1186\/s40064-016-3200-7","article-title":"Assessing potential impacts of the EVFTA on Vietnam's pharmaceutical imports from the EU: an application of SMART analysis","volume":"5","author":"HT Vu","year":"2016","journal-title":"SpringerPlus."},{"key":"pone.0240830.ref040","unstructured":"The Prime Minister. Decision approving the national strategy on development of the vietnam pharmaceutical industry up to 2020, with a vision toward 2030. issued on 10\/1\/20142014."},{"key":"pone.0240830.ref041","article-title":"The detailed regulation on guidelines for the list of pharmaceuticals with reimbursement by healthcare insurence","author":"Viet Nam Ministry of Health","year":"2018"},{"issue":"1","key":"pone.0240830.ref042","doi-asserted-by":"crossref","first-page":"e000082","DOI":"10.1136\/bmjgh-2016-000082","article-title":"Analysis of out-of-pocket costs associated with hospitalised injuries in Vietnam","volume":"2","author":"H Nguyen","year":"2017","journal-title":"BMJ Glob Health"},{"key":"pone.0240830.ref043","unstructured":"Vietnam's Prime Minister. Approving the national strategy to protect, care, and improve public health during 2011\u20132020 period, and the orientation towards 2030. No 122\/QD-TTg. 2013."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T17:26:56Z","timestamp":1603214816000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240830"}},"subtitle":[],"editor":[{"given":"Khin","family":"Thet Wai","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0240830","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,20]]}}}